SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-106641
Filing Date
2021-08-17
Accepted
2021-08-16 20:43:01
Documents
14
Period of Report
2021-08-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2125273d1_8k.htm   iXBRL 8-K 28236
2 EXHIBIT 99.1 tm2125273d1_ex99-1.htm EX-99.1 74337
3 GRAPHIC tm2125273d1_ex99-1img1.jpg GRAPHIC 13803
  Complete submission text file 0001104659-21-106641.txt   305659

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA elox-20210816.xsd EX-101.SCH 3197
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE elox-20210816_lab.xml EX-101.LAB 34593
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE elox-20210816_pre.xml EX-101.PRE 22718
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2125273d1_8k_htm.xml XML 3504
Mailing Address 480 ARSENAL WAY SUITE 130 WATERTOWN MA 02472
Business Address 480 ARSENAL WAY SUITE 130 WATERTOWN MA 02472 781-577-5300
Eloxx Pharmaceuticals, Inc. (Filer) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31326 | Film No.: 211180646
SIC: 8731 Services-Commercial Physical & Biological Research